A Tricistronic Retroviral Vector Expressing Natural Antiangiogenic Factors Inhibits Angiogenesis in Vitro, but Is Not Able to Block Tumor Progression in Vivo

Gene Therapy - United Kingdom
doi 10.1038/sj.gt.3301652
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Clodronate Inhibits Angiogenesis in Vitro and in Vivo

Oncology Reports
MedicineCancer ResearchOncology
2008English

Phenethyl Isothiocyanate Inhibits Angiogenesis in Vitro and Ex Vivo

Cancer Research
Cancer ResearchOncology
2007English

Pre-Existing Immunity to Adenovirus Does Not Prevent Tumor Regression Following Intratumoral Administration of a Vector Expressing IL-12 but Inhibits Virus Dissemination

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
1997English

Flexible Heteroarotinoid (Flex-Het) SHetA2 Inhibits Angiogenesis in Vitro and in Vivo

Investigational New Drugs
OncologyPharmacology
2008English

A Method to Assess Target Gene Involvement in Angiogenesis in Vitro and in Vivo Using Lentiviral Vectors Expressing shRNA

PLoS ONE
Multidisciplinary
2014English

Endothelial RhoA GTPase Is Essential for in Vitro Endothelial Functions but Dispensable for Physiological in Vivo Angiogenesis

Scientific Reports
Multidisciplinary
2019English

An Ad5[E1-, E2b-]-Her2/Neu Vector Induces Immune Responses and Inhibits HER2/neu Expressing Tumor Progression in Ad5 Immune Mice

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2011English

Parotid Gland Tissue Is Able Partially to Assume Pituitary Functions Under the Influence of Hypothalamic Factors: In Vivo and in Vitro Studies

Journal of Endocrinology
EndocrinologyMetabolismDiabetes
1999English

The Metal-Nonoate Ni(SalPipNONO) Inhibits in Vitro Tumor Growth, Invasiveness and Angiogenesis

Oncotarget
Oncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy